Arrivent Biopharma inc (AVBP) - News Archive

Showing 2 of 2 results.

At the 2024 World Conference on Lung Cancer, ArriVent BioPharma presented compelling interim da...

Title : Promising Phase 1b Data Elevates ArriVent s Firmonertinib as a Leading Candidate for EGFR PACC Mutant NSCLCAt the 2024 World Conference on Lung Cancer, ArriVent BioPharma presented compelling interim data from t...

Sep 9, 2024 • Major Pharmaceutical Preparations Industry Clinical Study

ArriVent Announces a Multi-Target ADC Collaboration with Alphamab

Overview of ArriVent and Alphamab s Multi-Target ADC CollaborationIn a groundbreaking development within the pharmaceutical industry, ArriVent has recently announced a strategic collaboration with Alphamab. This partner...

Jun 5, 2024 • Major Pharmaceutical Preparations Industry Product Service News